Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PLRX crawled time : 13:20 save search
Pliant Therapeutics to Participate in Upcoming Investor Events
Published: 2023-03-01 (Crawled : 13:20) - globenewswire.com
PLRX | $11.88 -5.11% -5.39% 370K
|
Health Technology
|
| O: -0.56%
H: 1.8%
C: -0.79%
therapeutics
Pliant Therapeutics Announces FDA Clearance of Investigational New Drug Application for PLN-101095, A Novel Integrin Inhibitor for the Treatment of Solid Tumors
Published: 2023-02-02 (Crawled : 13:20) - globenewswire.com
PLRX | $11.88 -5.11% -5.39% 370K
|
Health Technology
|
| O: 0.64%
H: 2.42%
C: -1.93%
pln-1010 treatment fda clearance drug therapeutics tumors
Pliant Therapeutics Presents Preclinical Data Highlighting A Novel Approach for the Treatment of Muscular Dystrophies
Published: 2022-06-22 (Crawled : 13:20) - biospace.com/
PLRX | $11.88 -5.11% -5.39% 370K
|
Health Technology
|
| O: -1.46%
H: 9.43%
C: 5.39%
treatment preclinical therapeutics pre-clinical
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-74809 for the Treatment of Idiopathic Pulmonary Fibrosis
Published: 2022-05-03 (Crawled : 13:20) - biospace.com/
PLRX | $11.88 -5.11% -5.39% 370K
|
Health Technology
|
| O: 0.88%
H: 2.62%
C: -5.26%
pln-7480 treatment fda fibrosis designation therapeutics fast track designation
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.